第三節(jié)藥學(xué)詞匯_第1頁
第三節(jié)藥學(xué)詞匯_第2頁
第三節(jié)藥學(xué)詞匯_第3頁
第三節(jié)藥學(xué)詞匯_第4頁
第三節(jié)藥學(xué)詞匯_第5頁
已閱讀5頁，還剩5頁未讀， 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

藥學(xué)詞匯：

drug：

prescription，recipe：

mediator，transmitter：

receptor：

ligand：

carrier：

Catecholamine:

Acetylcholine:

Cholinesterase:

electrolyte：

antigen：

complement：

antibody：

monoclonalantibody：

plasma：

serum：

hormone

prohormone

enzyme

coenzyme

proenzyme

Immunogenicity

prodrug

immunoenhancement

liposome：

allergy：

polyose：

dosage；dose

dosageform

powerfuldrug

tablet

capsule

disintegrant

additive

solute

solvent；dissolvent

dissolution

concentration

saturatedsolution

Diffusion

Mole

Molarity

Filtration

hydrolysis

tolerance

sensitivity

selectivity

potency

effect

hyperreactivity

antagonist

activator

detoxication

endotoxin

neurotoxin

anaphylatoxin

anatoxin，toxoid

superinfection

alkaloid

gluconeogenesis

carcinogenesis

bioavailability

chemotherapy

hemolysis

nucleotide

gene

protein

mutation

isotope

freezing，refrigeration

psychicdependence

physicaldependence

additiveeffect

drugtolerance

potencyunit

tablethardness

gasanalysis

antibacterialspectrum

bactericidalactivity

bactericidaleffect

semisyntheticantibiotics

broad-spectrumantibiotic

artificialantigen

artificialimmunization

blood-cerebralbarrier

bloodconcentration

bloodproducts

plasmaproteinbindingratio

intravascularadministration

extravascularadministration

adrenergicnerve

adrenergicreceptor

osmoticpressure

bodysurfacearea

crudedrugs;naturaldrugs

targetcell

drug-timecurve

growthcurve

time-effectrelationship

biologicalhalflife

biologicalproduct

receptorstimulant

receptorantagonist

drugmetabolism

drugdistribution

drugexcretion

drugabsorption

druginteraction

drugelimination

drugaccumulation

drugreaction

drug-induceddisease

drugstandard

absorptionrateconstant

relativedosageinterval

eliminationrateconstant

peakconcentrationofdrug

peaktimeofdrug

drugsensitivetest

thresholddose

therapeuticdose

therapeuticindex；TI

therapeuticaction

therapeuticdrugmonitoring;TDM

percentageconcentration

double-blindtechnique

drugbatchnumber

expirydate;dateofexpiration

steadystateplasmaconcentration

safetyrange

dosinginterval

toxicresponse;toxicreaction

chelatingagent

film-coating

passiveimmunity

passivetransport

activetransport

etiologicaltreatment

symptomatictreatment

essentialaminoacid

essentialfattyacid

surfacetension

surfaceactivity

gammarays

complementsystem

entericcoating

longtermtoxicitytest

penetrationenhancers

lowdensitylipoprotein

multifunctionalenzyme

multipledoseadministration

acutetoxicitytest

firstpasseffectofhepar

covalentbond

contentuniformity

nondepolarizer

traceelement

drugcombination

syntheticdrugs

chemicalanalysis

chemicaldisinfection

essentialdrugs

tricarboxylicacidcycle

blood-cerebralbarrier

bloodconcentration

bloodproducts

plasmaproteinbindingratio

intravascularadministration

extravascularadministration

adrenergicnerve

adrenergicreceptor

osmoticpressure

bodysurfacearea

crudedrugs;naturaldrugs

targetcell

drug-timecurve

growthcurve

time-effectrelationship

biologicalhalflife

biologicalproduct

receptorstimulant

receptorantagonist

drugmetabolism

drugdistribution

drugexcretion

drugabsorption

druginteraction

drugelimination

drugaccumulation

drugreaction

drug-induceddisease

drugstandard

absorptionrateconstant

relativedosageinterval

eliminationrateconstant

peakconcentrationofdrug

peaktimeofdrug

drugsensitivetest

thresholddose

therapeuticdose

therapeuticindex；TI

therapeuticaction

therapeuticdrugmonitoring;TDM

percentageconcentration

double-blindtechnique

drugbatchnumber

expirydate;dateofexpiration

steadystateplasmaconcentration

safetyrange

dosinginterval

toxicresponse;toxicreaction

chelatingagent

film-coating

passiveimmunity

passivetransport

activetransport

etiologicaltreatment

symptomatictreatment

essentialaminoacid

essentialfattyacid

surfacetension

surfaceactivity

gammarays

complementsystem

entericcoating

longtermtoxicitytest

penetrationenhancers

monoclonalantibody

lowdensitylipoprotein

multifunctionalenzyme

multipledoseadministration

acutetoxicitytest

first

溫馨提示

  • 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間，僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理，對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請(qǐng)與我們聯(lián)系，我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論